These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 26950683
1. Effects of Transdermal Testosterone Gel or an Aromatase Inhibitor on Prostate Volume in Older Men. Dias JP, Melvin D, Shardell M, Ferrucci L, Chia CW, Gharib M, Egan JM, Basaria S. J Clin Endocrinol Metab; 2016 Apr; 101(4):1865-71. PubMed ID: 26950683 [Abstract] [Full Text] [Related]
2. Effects of transdermal testosterone gel or an aromatase inhibitor on serum concentration and pulsatility of growth hormone in older men with age-related low testosterone. Dias JP, Veldhuis JD, Carlson O, Shardell M, Chia CW, Melvin D, Egan JM, Basaria S. Metabolism; 2017 Apr; 69():143-147. PubMed ID: 28285644 [Abstract] [Full Text] [Related]
3. Effects of aromatase inhibition vs. testosterone in older men with low testosterone: randomized-controlled trial. Dias JP, Melvin D, Simonsick EM, Carlson O, Shardell MD, Ferrucci L, Chia CW, Basaria S, Egan JM. Andrology; 2016 Jan; 4(1):33-40. PubMed ID: 26588809 [Abstract] [Full Text] [Related]
4. The role of aromatization in testosterone supplementation: effects on cognition in older men. Cherrier MM, Matsumoto AM, Amory JK, Ahmed S, Bremner W, Peskind ER, Raskind MA, Johnson M, Craft S. Neurology; 2005 Jan 25; 64(2):290-6. PubMed ID: 15668427 [Abstract] [Full Text] [Related]
5. Testosterone vs. aromatase inhibitor in older men with low testosterone: effects on cardiometabolic parameters. Dias JP, Shardell MD, Carlson OD, Melvin D, Caturegli G, Ferrucci L, Chia CW, Egan JM, Basaria S. Andrology; 2017 Jan 25; 5(1):31-40. PubMed ID: 27792869 [Abstract] [Full Text] [Related]
14. Short-term effects of intramuscular and transdermal testosterone on bone turnover, prostate symptoms, cholesterol, and hematocrit in men over age 70 with low testosterone levels. Kenny AM, Prestwood KM, Raisz LG. Endocr Res; 2000 May 25; 26(2):153-68. PubMed ID: 10921445 [Abstract] [Full Text] [Related]
16. Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. Amory JK, Watts NB, Easley KA, Sutton PR, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL. J Clin Endocrinol Metab; 2004 Feb 25; 89(2):503-10. PubMed ID: 14764753 [Abstract] [Full Text] [Related]
17. Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men. Leder BZ, Finkelstein JS. Osteoporos Int; 2005 Dec 25; 16(12):1487-94. PubMed ID: 15856361 [Abstract] [Full Text] [Related]
18. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. Marks LS, Mazer NA, Mostaghel E, Hess DL, Dorey FJ, Epstein JI, Veltri RW, Makarov DV, Partin AW, Bostwick DG, Macairan ML, Nelson PS. JAMA; 2006 Nov 15; 296(19):2351-61. PubMed ID: 17105798 [Abstract] [Full Text] [Related]
19. Aromatase activity after a short-course of letrozole administration in adult men at sea level and at high altitude (with or without excessive erythrocytosis). Gonzales GF, Tapia V, Gasco M, Gonzales-Castañeda C. Horm Metab Res; 2012 Feb 15; 44(2):140-5. PubMed ID: 22274717 [Abstract] [Full Text] [Related]
20. Dutasteride in men receiving testosterone therapy: a randomised, double-blind study. Kacker R, Harisaran V, Given L, Miner M, Rittmaster R, Morgentaler A. Andrologia; 2015 Mar 15; 47(2):148-52. PubMed ID: 24499051 [Abstract] [Full Text] [Related] Page: [Next] [New Search]